Ortho Clinical Diagnostics launches two COVID-19 antibody tests with 100% specificity claim

Ortho Clinical Diagnostics launches two COVID-19 antibody tests with 100% specificity claim

The US-multinational diagnostics solutions company Ortho Clinical Diagnostics has launched two of its latest antibody test kits for COVID-19 immunity check in India with a claim of 100% specificity compliance. Introducing these test kits in the local market, the company said that unlike other antibody test kits available in the market,  Ortho’s high-throughput, automated antibody testsare highly reliable and have demonstrated 100% specificity in assay validation studies.

The new test kits, branded as Vitros Anti-SARS-CoV-2 Total and IgG tests, can help to identify with high accuracy a previously infected patient who can donate antibody-containing plasma to treat severe COVID-19 patients, the company claimed.

“Our test kits have been approved by the CE and the FDA (EUA). They are widely used by prestigious hospitals and labs, such as Quest Labs, in the US,” said  Anand Pande,Vice-President- Asia-Pacific Region, Ortho Clinical Diagnostics.

Ortho’s instruments are used for HIV, HBsAg and HCV screening across the world and the technology is being used for blood screening for more than 25 years in prestigious hospitals and blood banks in India and other SAARC countries, he added.

“The process control audit trail for each step of analysis (of these test kits) is available to provide confidence in reporting,” said Pande.